Basel Medical Group Ltd Ordinary Shares Cash Flow Reinvestment Rate
Basel Medical Group Ltd Ordinary Shares cash flow reinvestment rate. Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow Reinvestment Rate of 0.01x as of June 2024, reinvesting $15.84K (capex $7.92K plus investments $-7.92K) from operating cash flow of $2.51 Million. Explore Basel Medical Group Ltd Ordinary Shares cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Basel Medical Group Ltd Ordinary Shares (2022–2024)
Cash flow reinvestment rate of Basel Medical Group Ltd Ordinary Shares from 2022 to 2024. Historical reinvestment intensity for Basel Medical Group Ltd Ordinary Shares across 3 annual periods. Explore Basel Medical Group Ltd Ordinary Shares capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Basel Medical Group Ltd Ordinary Shares Cash Flow Reinvestment Rate by Year (2022–2024)
Basel Medical Group Ltd Ordinary Shares cash flow reinvestment rate by year from 2022 to 2024. Year-by-year capital reinvestment analysis for Basel Medical Group Ltd Ordinary Shares. For the full cash flow conversion analysis, see BMGL cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.01x | $15.84K | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $12.32K | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.06x | $176.99K | $2.79 Million | $88.50K | — |